You do not have the latest flash plugin or you have disabled javascript.

Posted in General Blog, Pharmaceuticals Blog

FDA keeps Avandia on the market despite heart attack risks

July 31st, 2007 by Todd Hageman

Yesterday, the FDA held an advisory committee meeting to determine whether the diabetes drug Avandia should be kept on the market after studies revealed serious side effects.  The advisory committee concluded that Avandia poses elevated risks of heart attacks.  However, the committee decided Avandia should remain on the market but with stronger warnings, the New York Times reports.  The committee, in effect, overruled concerns from maverick physician David Graham.

If you or someone you know has been hurt as a result of taking Avandia, please call Simon Passanante attorney Todd Hageman toll free at 1-877-767-3108.  

Share This

 

Simon Passanante is nationally recognized as a result of its successful handling of jury trials on a wide variety of cases. You are invited to view the firm’s notable verdicts and settlements. Much of the information on this site is presented through videos. Other pages of this site concern Simon Passanante’s honors and awards, testimonials from clients and referring attorneys, and safety information. Our employee directory is here. If you have any questions for us, email us. See this page for important legal disclosures and to learn about contingent fees. For updates regarding Simon Passanante, we invite you to explore our law blogs.

Simon Passanante PC

701 Market Street

Suite 1450

St. Louis, Missouri 63101

314.241.2929

Toll Free: 877.767.3108

Close
E-mail It